← Previous Post: | Next Post:

 

“Prosecutors say the data were ascertained to have been altered in many cases. We cannot help but wonder why the medical doctors at the universities were unaware of what happened. Laboratories of those universities have so far received more than ¥1.1 billion in research funding from Novartis Pharma. The possibility is high that the back-scratching relations between universities, who are eager to obtain cash from businesses, and Novartis, out to exploit research results to promote its drug sales, may have formed a hotbed of wrongdoing.”

The Japanese have actually arrested someone in the Novartis scandal (background here). Color UD shocked. Color her shocked beyond recovery if the guy actually goes to jail for more than a day or two.

Novartis embedded one of its employees – made him a staff scientist – in five Japanese university laboratories. Five.

As a Novartis Pharma employee [Nobuo] Shirahashi took charge of analyzing data from clinical tests comparing Diovan and other blood pressure-lowing drugs at five Japanese universities … between 2002 and 2004.

How did that happen? How did a Diovan pusher get accepted – hired? – into five university labs in Japan and then take charge of clinical results?

That’s the ¥1.1 billion question, ain’t it?

Margaret Soltan, June 16, 2014 7:45AM
Posted in: foreign universities, march of science

Trackback URL for this post:
https://www.margaretsoltan.com/wp-trackback.php?p=44490

Comment on this Entry

Latest UD posts at IHE

Archives

Categories